Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme

By Martinez Ramon   Schackert Gabriele   Yaya-Tur Ricard   Rojas-Marcos Iñigo   Herman James   Esteller Manel  

Journal of Neuro-Oncology, Vol. 83, Iss. 1, 2007-05 ,pp. : 91-93

Springer Publishing Company

Access to resources Recommend Favorite

Association of prediagnostic physical activity with survival following breast cancer diagnosis: influence of TP53 mutation status

By Tao Meng-Hua   Hainaut Pierre   Marian Catalin   Nie Jing   Ambrosone Christine   Edge Stephen   Trevisan Maurizio   Dorn Joan   Shields Peter   Freudenheim Jo  

Cancer Causes and Control, Vol. 24, Iss. 12, 2013-12 ,pp. : 2177-2186

Springer Publishing Company

Access to resources Recommend Favorite

Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma

By Banzai Chiaki   Nishino Koji   Quan Jinhua   Yoshihara Kosuke   Sekine Masayuki   Yahata Tetsuro   Tanaka Kenichi  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 127-132

Springer Publishing Company

Access to resources Recommend Favorite

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite

TP53 Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast Cancer

By Overgaard Jens   Yilmaz Mette   Guldberg Per   Hansen Lise Lotte   Alsner Jan  

Acta Oncologica, Vol. 39, Iss. 3, 2000-10 ,pp. : 327-333

Informa Healthcare

Access to resources Recommend Favorite